Home NDC 0093-0017 Moexipril Hydrochloride
Product NDC 0093-0017
11-digit product format 000930017
Labeler code 0093
Product ID 0093-0017_2c29e2eb-8956-4fb2-a371-57466c82f348
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Moexipril Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA076204
Marketing category ANDA
Marketing start 2003-05-08
Substance MOEXIPRIL HYDROCHLORIDE
Active strength 7.5 mg/1
Pharmacologic classes Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076204-001 MOEXIPRIL HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 A076204-002 MOEXIPRIL HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076204-001 MOEXIPRIL HYDROCHLORIDE 7.5MG TABLET / ORAL AB 2003-05-08 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A076204-002 MOEXIPRIL HYDROCHLORIDE 15MG TABLET / ORAL AB RS 2003-05-08 782e0a99824c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 82 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Moexipril Hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MOEXIPRIL HYDROCHLORIDE 7.5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination Q1UMG3UH45 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1299896 Internal RxNorm lookup 1299897 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-0017-01 Moexipril Hydrochloride 100 in 1 BOTTLE TABLET, FILM COATED 100 11
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MOEXIPRIL HYDROCHLORIDE ACTIVE INGREDIENT Q1UMG3UH45 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 MOEXIPRILAT ACTIVE MOIETY H3753190JS MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 HYPROMELLOSE 2910 (15 MPA.S) INACTIVE INGREDIENT 36SFW2JZ0W MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 HYPROMELLOSE 2910 (3 MPA.S) INACTIVE INGREDIENT 0VUT3PMY82 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] 6 MOEXIPRIL HYDROCHLORIDE ACTIVE INGREDIENT Q1UMG3UH45 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 MOEXIPRILAT ACTIVE MOIETY H3753190JS MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 HYPROMELLOSE 2910 (15 MPA.S) INACTIVE INGREDIENT 36SFW2JZ0W MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 HYPROMELLOSE 2910 (3 MPA.S) INACTIVE INGREDIENT 0VUT3PMY82 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 SODIUM BICARBONATE INACTIVE INGREDIENT 8MDF5V39QO MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [CARILION MATERIALS MANAGEMENT] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-0017 MOEXIPRIL HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA, INC.] 10 Current NDC, Legacy NDC, 1 package rows 20200829_5d4078f3-b621-475f-a4e6-005de2e62b32.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0093-0017-01 00093001701 100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01) 2003-05-08 0000-00-00 No No Current